Exact Sciences is a company that helps find and treat cancer. They did better than expected in the last three months, so their stock price went up. Some experts think the stock price will go up more in the future, so they changed their predictions. This made more people want to buy the stock, which made the price go up even more. Read from source...

- Article's title is misleading and sensationalized, implying that Exact Sciences slashed their forecasts, when in fact they beat both earnings and revenue estimates.
- Article's content is vague and uninformative, it does not provide any details about the reasons behind the analysts' adjustments, or the company's performance and outlook.
- Article's tone is negative and dismissive, it uses words like "slashed", "better-than-expected", "slamming", "shares plummeted", "cut", etc. to convey a sense of gloom and doom.
- Article's sources are questionable and unreliable, it cites only one analyst, Stifel's AIiel Arias, without providing any context or reasoning for his price target reduction. It also cites Benzinga's own website as a source of news, which is a conflict of interest and a poor journalistic practice.